Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (1)
  • Autophagy
    (1)
  • FLT
    (1)
  • IRE1
    (1)
  • Mitophagy
    (1)
  • PDGFR
    (1)
  • VEGFR
    (1)
  • c-Kit
    (1)
  • Others
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (1)
  • Others
    (1)
Filter
Search Result
Results for "

557795-19-4

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    2
    TargetMol | All_Pathways
  • Reference Standards
    1
    TargetMol | Standard_Products
Sunitinib
SU 11248
T0374L557795-19-4
Sunitinib (SU 11248) is a multi-targeted receptor tyrosine kinase (RTK) inhibitor that inhibits VEGFR2 and PDGFRβ (IC50=80/2 nM). It exhibits antitumor activity and is used for treating kidney cancer and gastrointestinal tumors.
  • $30
In Stock
Size
QTY
TargetMol | Citations Cited
Sunitinib (Standard)
TMSM-3447557795-19-4
Sunitinib (Standard) is a reference standard for research and analysis in studies involving Sunitinib. Sunitinib (SU 11248) is a multi-targeted receptor tyrosine kinase (RTK) inhibitor that inhibits VEGFR2 and PDGFRβ (IC50=80/2 nM). Sunitinib has antitumor activity and can be used for the treatment of kidney cancer and gastrointestinal tumors.
  • $128
7-10 days
Size
QTY